960化工网
Development of an MRI contrast agent for both detection and inhibition of the amyloid-β fibrillation process†
Rohmad Yudi Utomo,Akira Sumiyoshi,Ichio Aoki
RSC Advances Pub Date : 02/09/2022 00:00:00 , DOI:10.1039/D2RA00614F
Abstract

A curcumin derivative conjugated with Gd-DO3A (Gd-DO3A-Comp.B) was synthesised as an MRI contrast agent for detecting the amyloid-β (Aβ) fibrillation process. Gd-DO3A-Comp.B inhibited Aβ aggregation significantly and detected the fibril growth at 20 μM of Aβ with 10 μM of probe concentration by T1-weighted MR imaging.

Graphical abstract: Development of an MRI contrast agent for both detection and inhibition of the amyloid-β fibrillation process
平台客服
平台客服
平台在线客服